Evidence map›Paper›PMID 29345196›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2018

Surfactant protein C dampens inflammation by decreasing JAK/STAT activation during lung repair.

Huiyan Jin, Andrzej K Ciechanowicz, Alanna R Kaplan, Lin Wang, Ping-Xia Zhang, Yi-Chien Lu, Rachel E Tobin, Brooke A Tobin, Lauren Cohn, Caroline J Zeiss and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor.Journal of respiratory biology and translational medicine · 2024
    Article
  6. Article
  7. Baicalin and lung diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  8. Article
  9. Abnormal Fetal Lung of Hoxa1Animals : an open access journal from MDPI · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Huiyan JinDepartment of Cell Biology, Yale School of Medicine , New Haven, Connecticut.
Andrzej K CiechanowiczDepartment of Regenerative Medicine, Centre for Preclinical Research and Technology, Medical University of Warsaw , Warsaw , Poland.
Alanna R KaplanDepartment of Pathology, Yale School of Medicine , New Haven, Connecticut.
Lin WangYale Stem Cell Center, Yale University , New Haven, Connecticut.
Ping-Xia ZhangYale Stem Cell Center, Yale University , New Haven, Connecticut.
Yi-Chien LuYale Stem Cell Center, Yale University , New Haven, Connecticut.
Rachel E TobinYale Stem Cell Center, Yale University , New Haven, Connecticut.
Brooke A TobinYale Stem Cell Center, Yale University , New Haven, Connecticut.
Lauren CohnDepartment of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine , New Haven, Connecticut.
Caroline J ZeissDepartment of Comparative Medicine, Yale School of Medicine , New Haven, Connecticut.
Patty J LeeDepartment of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine , New Haven, Connecticut.
Emanuela M BrusciaDepartment of Pediatrics, Yale School of Medicine , New Haven, Connecticut.
Diane S KrauseDepartment of Cell Biology, Yale School of Medicine , New Haven, Connecticut.
Yale University · USYale Cancer Center · USMedical University of Warsaw · PL

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
CFTR and Toll-Like Receptor SignalingR01HL123851 · NHLBI · YALE UNIVERSITY · PI BRUSCIA, EMANUELA MARINA · 2016 to 2019
$1.7M
TLR4-MEDIATED EPIGENETIC AND SENESCENCE MECHANISMS IN EMPHYSEMAR01HL138396 · NHLBI · YALE UNIVERSITY · PI LEE, PATTY J · 2017 to 2020
$1.5M
NHLBI NIH HHS R01 HL123851NHLBI NIH HHS R01 HL138396NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Surfactant protein C (SPC), a key component of pulmonary surfactant, also plays a role in regulating inflammation. SPC deficiency in patients and mouse models is associated with increased inflammation and delayed repair, but the key drivers of SPC-regulated inflammation in response to injury are largely unknown. This study focuses on a new mechanism of SPC as an anti-inflammatory molecule using SPC-TK/SPC-KO (surfactant protein C-thymidine kinase/surfactant protein C knockout) mice, which represent a novel sterile injury model that mimics clinical acute respiratory distress syndrome (ARDS). SPC-TK mice express the inducible suicide gene thymidine kinase from by the SPC promoter, which targets alveolar type 2 (AT2) cells for depletion in response to ganciclovir (GCV). We compared GCV-induced injury and repair in SPC-TK mice that have normal endogenous SPC expression with SPC-TK/SPC-KO mice lacking SPC expression. In contrast to SPC-TK mice, SPC-TK/SPC-KO mice treated with GCV exhibited more severe inflammation, resulting in over 90% mortality; there was only 8% mortality of SPC-TK animals. SPC-TK/SPC-KO mice had highly elevated inflammatory cytokines and granulocyte infiltration in the bronchoalveolar lavage (BAL) fluid. Consistent with a proinflammatory phenotype, immunofluorescence revealed increased phosphorylated signal transduction and activation of transcription 3 (pSTAT3), suggesting enhanced Janus kinase (JAK)/STAT activation in inflammatory and AT2 cells of SPC-TK/SPC-KO mice. The level of suppressor of cytokine signaling 3, an anti-inflammatory mediator that decreases pSTAT3 signaling, was significantly decreased in the BAL fluid of SPC-TK/SPC-KO mice. Hyperactivation of pSTAT3 and inflammation were rescued by AZD1480, a JAK1/2 inhibitor. Our findings showing a novel role for SPC in regulating inflammation via JAK/STAT may have clinical applications.

Indexed as

Disease Models, AnimalAnimalsIntercellular Signaling Peptides and ProteinsJanus Kinase 1Lung InjuryMiceMice, Inbred C57BLMice, KnockoutPeptidesPhosphorylationPneumoniaPulmonary Surfactant-Associated Protein CSTAT3 Transcription FactorThymidine KinaseIntercellular Signaling Peptides and ProteinsJak1 protein, mouseJanus Kinase 1PeptidesPulmonary Surfactant-Associated Protein CSftpc protein, mouseStat3 protein, mouseSTAT3 Transcription FactorThymidine Kinasealveolar macrophagesalveolar type 2 cellsinflammationJAK/STATsurfactant protein C

Identifiers

PMID29345196
PMCPMC6008135
OpenAlexW2783779739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.